Clinical Report: Comprehensive Analysis of Macrophage States in Atherosclerosis
Overview
Revise to include specific macrophage state programs and their clinical relevance.
Background
Atherosclerosis is a leading cause of cardiovascular disease, characterized by chronic inflammation and lipid accumulation. Understanding the diverse roles of macrophages within atherosclerotic plaques is crucial for developing targeted therapies and improving patient outcomes. Recent advances in single-cell and spatial profiling have revealed the complexity of macrophage states, linking them to clinically relevant features of atherosclerosis.
Data Highlights
No numerical data provided in the source material.
Key Findings
Macrophages in atherosclerotic plaques exhibit diverse transcriptional states, including inflammatory, lipid-associated, and reparative phenotypes.
These macrophage states are associated with critical clinical features such as symptomatic disease and plaque instability.
Macrophage abundance correlates with symptomatic presentation and cardiovascular events over three years.
Methodological heterogeneity in studies complicates the understanding of macrophage roles in atherosclerosis.
A coherent macrophage atlas can enhance the mechanistic understanding of plaque progression and inform clinical applications.
Clinical Implications
Clinicians should consider the diverse macrophage states when assessing atherosclerotic disease and its progression. Targeting specific macrophage phenotypes may offer new therapeutic avenues for risk stratification and treatment in patients with atherosclerosis.
Conclusion
The emerging understanding of macrophage states in atherosclerosis underscores their significance in disease progression and clinical outcomes. A unified framework for macrophage characterization may facilitate the development of targeted interventions.
